Journal
NATURE MEDICINE
Volume 28, Issue 2, Pages 345-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41591-021-01621-1
Keywords
-
Funding
- Lake Road Foundation
- Lymphoma and Leukemia Society
- Leopold Griffuel award
- NCI Cancer Center Support Grant [P30 CA008748]
- Cycle for Survival
- Marie-Josee and Henry R. Kravis Center for Molecular Oncology
- NCI [P30 CA08748]
- Canadian Institutes of Health Research
- Fogarty Foundation
- Alexander S. Onassis Public Benefit Foundation
- Tow Foundation
- Pasteur-Weizmann/Servier award
Ask authors/readers for more resources
HLA-independent T cell receptors (HIT receptors) are a novel type of chimeric antigen receptors that can effectively target tumors with low antigen expression, surpassing the sensitivity of CD28-based receptors. They offer high antigen sensitivity and can recognize tumors beyond the capabilities of other CAR designs. The functional persistence of HIT T cells can be enhanced by coexpression of CD80 and 4-1BBL. HIT receptors have been validated in xenograft mouse models, targeting CD19 and CD70 in B cell leukemia and acute myeloid leukemia, respectively.
HLA-independent T cell receptors, in which the heavy and light chains of a chimeric antigen receptor are incorporated into the endogenous T cell receptor locus, are more effective than CD28-based chimeric antigen receptors at targeting tumors with low antigen expression. Chimeric antigen receptors (CARs) are receptors for antigen that direct potent immune responses. Tumor escape associated with low target antigen expression is emerging as one potential limitation of their efficacy. Here we edit the TRAC locus in human peripheral blood T cells to engage cell-surface targets through their T cell receptor-CD3 complex reconfigured to utilize the same immunoglobulin heavy and light chains as a matched CAR. We demonstrate that these HLA-independent T cell receptors (HIT receptors) consistently afford high antigen sensitivity and mediate tumor recognition beyond what CD28-based CARs, the most sensitive design to date, can provide. We demonstrate that the functional persistence of HIT T cells can be augmented by constitutive coexpression of CD80 and 4-1BBL. Finally, we validate the increased antigen sensitivity afforded by HIT receptors in xenograft mouse models of B cell leukemia and acute myeloid leukemia, targeting CD19 and CD70, respectively. Overall, HIT receptors are well suited for targeting cell surface antigens of low abundance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available